TY  - JOUR 
AU  - Martinón Torres, Federico
AU  - Nolan, T.
AU  - Toneatto, D.
AU  - Banzhoff, A.
PY  - 2019
SN  - 2164-5515
UR  - http://hdl.handle.net/20.500.11940/15502
AB  - The multicomponent meningococcal serogroup B vaccine, 4CMenB, has demonstrated effectiveness in preventing invasive MenB disease in infants and in controlling MenB outbreaks. The need for/timing of additional booster doses is not yet established. We...
TI  - Persistence of the immune response after 4CMenB vaccination, and the response to an additional booster dose in infants, children, adolescents, and young adults
DO  - 10.1080/21645515.2019.1627159
T2  - Human Vaccines & Immunotherapeutics 
M2  - 2940
KW  - CHUS
VL  - 15
ER  -